14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today BLPH ranks #17182 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Bellerophon Therapeutics Stock Forecast NASDAQ:BLPH

$2.65 (-6.69%)

Volume: 41k

Closed: Dec 03, 2021

Hollow Logo Score: -7.000

Bellerophon Therapeutics Stock Forecast

$2.65 (-6.69%)

Volume: 41k

Closed: Dec 03, 2021

Score Hollow Logo -7.000
Which way will BLPH go? Request
Key Stats
Beta 0.4
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 38 and the stock is currently not being overbought or oversold

Volatile ride for Bellerophon Therapeutics stock price on Friday moving between $2.60 and $2.87
(Updated on Dec 03, 2021)

Sell candidate since 2021-11-18 Loss -28.95%

The Bellerophon Therapeutics stock price fell by -6.69% on the last day (Friday, 3rd Dec 2021) from $2.84 to $2.65. During the day the stock fluctuated 10.38% from a day low at $2.60 to a day high of $2.87. The price has fallen in 6 of the last 10 days and is down by -28.95% for this period. Volume has increased on the last day by 20 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 41 thousand shares were bought and sold for approximately $109.49 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.91) are considered to be a "second chance" to get out. According to the fan-theory $2.18 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Bellerophon Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.04 and $3.49. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, November 17, 2021, and so far it has fallen -30.63%. Further fall is indicated until a new bottom pivot has been found. Bellerophon Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.27 between high and low, or 10.38%. For the last week, the stock has had a daily average volatility of 7.93%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Bellerophon Therapeutics stock A Buy?

Bellerophon Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.000

Predicted Opening Price for Bellerophon Therapeutics of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$2.71 $2.65 (Undervalued)
Strong Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Maxim Group is very positive about BLPH and gave it a "Buy" rating on Nov 06, 2020. The price target was set to $22.00.

Volatility and Risk
Daily Average Volatility: 7.93 %
Overall Risk: Very High High Medium Low Very Low
7.93 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $2.82
Price: $2.65
No Support Found

BLPH Insider Trading Show all Trades



Last 100 transactions
Buy: 12 618 935 | Sell: 2 393 588 (Shares)
Date Action Amount Person Type
Jun 07, 2021 Buy 8 189 Puissance Life Science Opportunities Fund Vi Common Stock
Apr 26, 2021 Buy 304 286 Puissance Life Science Opportunities Fund Vi Warrants (Right to buy)
Apr 26, 2021 Buy 609 231 Puissance Life Science Opportunities Fund Vi Common Stock
Apr 26, 2021 Buy 380 950 Puissance Life Science Opportunities Fund Vi Warrants (Right to buy)
Mar 31, 2021 Buy 15 308 Peacock Jonathan M Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 12 618 935 | Sell: 2 393 588 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 2.98 12.33 %
2.87 8.43 %
2.81 6.03 %
Current price: 2.65
Support 2.60 -1.75 %
2.54 -4.16 %
2.44 -8.05 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 3.25 22.64 %
3.18 20.00 %
2.82 6.42 %
Current price 2.65
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates include INOpulse, a pulsatile nitric oxide delivery device, which has completed Phase II clinical trials for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trials... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE